5HT2 agonists for controlling IOP and treating glaucoma

Details for Australian Patent Application No. 2001216071 (hide)

International Classifications

Event Publications

2 December 2004 Application Accepted

Published as AU-B-2001216071

7 April 2005 Standard Patent Sealed

12 January 2006 Change of Name(s) of Applicant(s), Section 104

Alcon, Inc.; Yamanouchi Pharmaceutical Co., Ltd The name of the applicant has been changed to Astellas Pharma Inc.; Alcon, Inc.

13 July 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.